Dr. Schmittgen’s research interests include cancer therapeutics, exosomes as targeted drug delivery systems and the role of noncoding RNAs in cancer initiation and progression.

Dr. Bihorel’s research interests include leading-edge experimental and computational techniques to rationally optimize sequence combination therapies of anti-cancer drugs; bench-to-bedside, multiscale, system-based PK/PD models in oncology; novel nanodelivery system development for cancer therapy.

Dr. Hochhaus’ research interests include the relationship between the drug and formulation properties of inhalation drugs, their pharmacokinetic and dynamic properties, and bioequivalence pharmacodynamic effects.

Dr. Mobley’s Research interests include application of instructional design principles to optimize student pharmacist learning and the application of critical thinking and reasoning skills to help develop problem-solving abilities.

Dr. Schmidt’s research interests include the application of quantitative analysis tools to address clinically relevant research questions in the areas of antimicrobial chemotherapy, pediatrics, diabetes, cardiovascular safety and postmenopausal osteoporosis.

Dr. Song’s research interests include adeno-associated virus, or AAV, vector biology, liver and muscle gene delivery, novel function of alpha 1 antitrypsin, or AAT, AAT deficiency and autoimmune and inflammatory diseases.

Dr. Vozmediano’s research interests include model-informed drug development for strategic decision making in special populations, implementation of pharmacometric-based regulatory strategies, and application of translational research to animal health.